Security key
09071M205
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX)
CUSIP: 09071M205
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Ordinary shares, par value NIS 0.10 per share
- Total 13F shares
- 2,485,707
- Total 13F value
- $1,330,214
- Share change
- -939,853
- Put/Call ratio
- 14%
- SEC-reported price per share
- $0.54
- Number of holders
- 30
- Value change
- -$508,007
- Number of buys
- 13
- Number of sells
- 11
- Shares outstanding
- 2,048,819,940
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
30
Top holders
10
BLRX full security history
Ownership snapshot
Full 13F holder table
BioLineRx Ltd. SEC filings
BioLineRx Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Alyeska Investment Group,...
Disclosed value leader
Alyeska Investment Group,...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 0.1%
Showing 1-6 of 15 holder rows.
Quick read
Alyeska Investment Group, L.P. leads the comparable SEC ownership view at 0.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Alyeska Investment Group, L.P.'s linked filing trail.
Comparable ownership
Top 5
Alyeska Investment Group, L.P.
0.1%
CVI Holdings, LLC
0.04%
ENVESTNET ASSET MANAGEMENT INC
0.01%
Values First Advisors, Inc.
0.01%
PVG ASSET MANAGEMENT CORP
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. |
13F
Company
|
0.1%
|
$1,113,223
1,953,366 shares
|
— | 30 Jun 2024 |
| CVI Holdings, LLC |
13F
Company
|
0.04%
|
$461,677
815,683 shares
|
— | 30 Jun 2024 |
| ENVESTNET ASSET MANAGEMENT INC |
13F
Company
|
0.01%
|
$121,863
213,833 shares
|
— | 30 Jun 2024 |
| Values First Advisors, Inc. |
13F
Company
|
0.01%
|
$116,122
203,759 shares
|
— | 30 Jun 2024 |
| PVG ASSET MANAGEMENT CORP |
13F
Company
|
0.01%
|
$70,428
123,580 shares
|
— | 30 Jun 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.01%
|
$66,890
118,180 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
30
Shares
2,485,707
Rows available
30
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
30
Q3 2024 holders
30
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|